Heron Therapeutics (HRTX) Inventory Average (2016 - 2026)

Heron Therapeutics has reported Inventory Average for 11 years, with the latest figure at $92.6 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 68.3% year-over-year to $92.6 million; the trailing twelve-month figure through Mar 2026 stood at $92.6 million (up 68.3% YoY), and the FY2025 full-year result was $73.0 million, up 53.15% from the prior year.
• Inventory Average for Q1 2026 stood at $92.6 million, up from $81.4 million in the prior quarter.
• The five-year high for Inventory Average was $92.6 million in Q1 2026, with the low at $21.1 million in Q1 2024.
• Historically, Inventory Average has averaged $53.6 million across 5 years, with a median of $53.3 million in 2023.
• Annual changes were most pronounced in 2024 — Inventory Average slumped 60.42% — and 2025, when it jumped 202.34%.
• Heron Therapeutics' Inventory Average stood at $53.4 million in 2022, then decreased by 21.25% to $42.1 million in 2023, then climbed by 17.82% to $49.6 million in 2024, then jumped by 64.23% to $81.4 million in 2025, then rose by 13.83% to $92.6 million in 2026.
• The last three Inventory Average figures came in at $92.6 million (Q1 2026), $81.4 million (Q4 2025), and $71.5 million (Q3 2025), per Business Quant data.